The abuse liability of ketamine: A scoping review of preclinical and clinical studies.
Journal of Psychiatric Research May 1, 2022 Tuyen T. Le, Isabel Pazos Cordero, Muhammad Youshay Jawad et al. 82 citations
While ketamine has been used clinically over the past decades, it has only been recently shown to be a promising therapy for treatment-resistant depression (TRD). However, ketamine and related dissociative agents may also be misused recreationally, creating significant concerns for abuse liability when prescribed for depression. Although the abuse potential of ketamine is widely recognized,...